Graham Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-94,815
Closed -$135K 1398
2022
Q4
$135K Sell
94,815
-249,107
-72% -$534K ﹤0.01% 989
2022
Q3
$839K Sell
343,922
-6,532
-2% -$21.8K 0.03% 561
2022
Q2
$795K Buy
350,454
+298,197
+571% +$1.11M 0.03% 513
2022
Q1
$351K Buy
52,257
+42,068
+413% +$360K 0.01% 682
2021
Q4
$92K Buy
+10,189
New +$94.7K ﹤0.01% 509

Other funds holding DBD

Graham Capital Management's DBD Position: Q1 2023 in Review

Graham Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 94,815 shares — an estimated $135K sold.

Graham Capital Management first reported a position in DBD in Q4 2021 and held it in 5 quarters. The position peaked at $839K in Q3 2022. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • Graham Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • Graham Capital Management sold 94,815 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $135K.
  • Graham Capital Management first reported a position in Diebold Nixdorf Incorporated in Q4 2021 and held it in 5 quarters.
  • Graham Capital Management's Diebold Nixdorf Incorporated position peaked at $839K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on Graham Capital Management's 13F filing for Q1 2023, filed 15 May 2023.